GLP-1 receptor agonists in kidney transplant recipients with pre-existing diabetes: a retrospective cohort study

In a large US registry of diabetic kidney-transplant recipients, those who started a GLP-1 receptor agonist after transplant had roughly half the risk of graft loss and about one-third lower mortality, though randomized confirmation is still needed.